Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
IN RE: BLOOD REAGENTS ANTITRUST LITIGATION
Case Number:
2:09-md-02081
Court:
Nature of Suit:
Multi Party Litigation:
Multi-district Litigation
Judge:
-
July 13, 2018
Ortho's $19.5M Deal Ending Antitrust MDL Gets Initial OK
A Pennsylvania federal judge on Thursday greenlighted Ortho-Clinical Diagnostics Inc.'s $19.5 million deal to resolve allegations in multidistrict litigation that the former Johnson & Johnson unit conspired with another company to fix prices on the reagents used in blood tests.
-
October 19, 2015
Purchasers Win Cert. Again In Blood Test Antitrust MDL
A Pennsylvania federal judge on Monday recertified a class of buyers of reagents used in blood tests in multidistrict litigation alleging that a former Johnson & Johnson unit conspired with another company to fix prices on the reagents.
-
August 23, 2012
Purchaser Class Certified In J&J Blood Test Antitrust MDL
A Pennsylvania federal judge on Wednesday said buyers of reagents used in blood tests had satisfied the requirements to certify a class in an action alleging that a Johnson & Johnson unit conspired with another company to fix prices on the reagents.
-
March 05, 2012
Immucor To Pay $22M To Stanch Blood Test Antitrust Action
Immucor Inc. has agreed to pay $22 million to resolve its part in a class action alleging it conspired with a Johnson & Johnson unit to fix prices of blood-testing reagents, according to a settlement agreement granted preliminary approval Monday.